- Home
- ABEO vs SI Comparison
ABEO vs SI Comparison
Compare ABEO & SI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- SI
- Stock Information
- Founded
- ABEO 1974
- SI 2009
- Country
- ABEO United States
- SI United States
- Employees
- ABEO N/A
- SI N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- SI Medical/Dental Instruments
- Sector
- ABEO Health Care
- SI Health Care
- Exchange
- ABEO Nasdaq
- SI Nasdaq
- Market Cap
- ABEO 350.2M
- SI 299.6M
- IPO Year
- ABEO 1980
- SI 2025
- Fundamental
- Price
- ABEO $5.73
- SI $14.96
- Analyst Decision
- ABEO Strong Buy
- SI Strong Buy
- Analyst Count
- ABEO 6
- SI 5
- Target Price
- ABEO $18.17
- SI $19.60
- AVG Volume (30 Days)
- ABEO 714.3K
- SI 149.7K
- Earning Date
- ABEO 11-13-2025
- SI 09-09-2025
- Dividend Yield
- ABEO N/A
- SI N/A
- EPS Growth
- ABEO N/A
- SI N/A
- EPS
- ABEO 0.99
- SI N/A
- Revenue
- ABEO $400,000.00
- SI $37,324,000.00
- Revenue This Year
- ABEO N/A
- SI N/A
- Revenue Next Year
- ABEO $324.71
- SI N/A
- P/E Ratio
- ABEO $5.80
- SI N/A
- Revenue Growth
- ABEO N/A
- SI 64.07
- 52 Week Low
- ABEO $3.93
- SI $11.75
- 52 Week High
- ABEO $7.54
- SI $17.94
- Technical
- Relative Strength Index (RSI)
- ABEO 31.45
- SI N/A
- Support Level
- ABEO $6.53
- SI N/A
- Resistance Level
- ABEO $6.95
- SI N/A
- Average True Range (ATR)
- ABEO 0.29
- SI 0.00
- MACD
- ABEO -0.12
- SI 0.00
- Stochastic Oscillator
- ABEO 3.39
- SI 0.00
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About SI Shoulder Innovations Inc. Common Stock
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.